Tailoring Bruton Tyrosine Kinase Inhibitor Strategies for CLL: Managing Today, Anticipating Tomorrow

Fine-Tuning Chronic Lymphocytic Leukemia Management: Optimising Bruton Tyrosine Kinase Inhibitor Use in Practice: What are the latest advances shaping chronic lymphocytic leukemia (CLL) treatment today? Discover the role of Bruton tyrosine kinase (BTK) inhibitors through our expert-led journey. Credit available for this activity expires: 5/29/25 Earn Credit /... by Keeping Current

35 min listen

Targeting BTK and Bcl-2 for B-Cell Malignancies: Where Are We Moving Toward?: Expert insights on the latest clinical findings on targeting Bruton tyrosine kinase (BTK) and B-cell lymphoma 2 (Bcl-2) to treat B-cell malignancies. Credit available for this activity expires: 1/12/25 Earn Credit / Learning Objectives & Disclosures: by Keeping Current CME

21 min listen

Bruton Tyrosine Kinase Inhibitors in B-Cell Malignancies: Multidisciplinary Perspectives on Managing and Maximizing Care: Do you know how adverse events (AEs) associated with Bruton tyrosine kinase (BTK) inhibitors affect patients’ lives and how best to manage these events? Credit available for this activity expires: 11/15/24 Earn Credit / Learning Objectives &... by Keeping Current

36 min listen

Optimizing Treatment Pathways in CLL and MCL: Evaluating and Applying Recent Data on BTK Inhibitors: Do you struggle with how to optimally interpret chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL)? Hear from the experts. Credit available for this activity expires: 3/29/25 Earn Credit / Learning Objectives & Disclosures: by Keeping Current CME

37 min listen

BTK Inhibitors for Chronic Lymphocytic Leukemia: Rapid-Fire Highlights From the Past Year: Do you know what the latest chronic lymphocytic leukemia (CLL) clinical data are and what this could mean for your patients? Credit available for this activity expires: 8/10/2024 Earn Credit / Learning Objectives & Disclosures: by Keeping Current

19 min listen

Relapsed/Refractory Chronic Lymphocytic Leukemia: The Evolving Role of BTK Inhibitors: Did you know that the National Comprehensive Cancer Network (NCCN) guidelines now include an investigational noncovalent BTK inhibitor for the treatment of relapsed/refractory CLL? Credit available for this activity expires: 12/05/24 Earn... by Keeping Current CME

29 min listen

$Relapsed/Refractory Chronic Lymphocytic Leukemia: The Evolving Role of BTK Inhibitors: Did you know that the National Comprehensive Cancer Network (NCCN) guidelines now include an investigational noncovalent BTK inhibitor for the treatment of relapsed/refractory CLL? Credit available for this activity expires: 12/05/24 Earn...$

Clinical Spotlight: Harnessing the Power of Antibody-Drug Conjugates in Non-Small Cell Lung Cancer: Antibody-drug conjugates are revolutionizing the therapeutic landscape for NSCLC. Are you up to date? Credit available for this activity expires: 1/24/2025 Earn Credit / Learning Objectives & Disclosures: by Keeping Current

38 min listen

Amit Bar-Or, MD, FRCPC / Daniel S. Reich, MD, PhD - Rationale, Evidence, and Practical Potential for BTK Inhibitors in Patient-Centered MS Care: Where We Stand Now: Go online to PeerView.com/TCY860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. by PeerView Internal Medicine CME/CNE/CPE Audio Podcast

53 min listen

Optimizing Treatment Selection in Immune Thrombocytopenia: A Patient Case Discussion: Did you know that there is a tendency among clinicians to overuse corticosteroids in the management of immune thrombocytopenia (ITP)? Credit available for this activity expires: 6/26/24 Earn Credit / Learning Objectives & Disclosures: by Keeping Current

34 min listen

Primary Biliary Cholangitis: Targeting New Treatment Goals: How familiar are you with emerging therapies for primary biliary cholangitis (PBC)? Credit available for this activity expires: 3/28/25 Earn Credit / Learning Objectives & Disclosures: by Keeping Current CME

15 min listen

Hepatitis C Screening and Beyond: Role of the Primary Care Team in Addressing Inequities: Are you screening all adults for viral hepatitis, as recommended by the Centers for Disease Control and Prevention (CDC)? Join 2 experts in a discussion of best practices. Credit available for this activity expires: 04/25/25 Earn Credit /... by Keeping Current CME

35 min listen

Identifying Progressive Pulmonary Fibrosis on Imaging and Collaborating With the Multidisciplinary Team: Do you know which high-resolution computed tomography (HRCT) patterns are associated with fibrosing interstitial lung disease and its progression? Credit available for this activity expires: 10/24/24 Earn Credit / Learning Objectives & Disclosures: by Keeping Current

38 min listen

Evolution of Oncogenic-Driven Early-Stage Resectable NSCLC: Testing and Practical Considerations: Are you aware that molecular testing is necessary to inform the appropriate adjuvant treatment decision for patients? Credit available for this activity expires: 3/22/25 Earn Credit / Learning Objectives & Disclosures: by Keeping Current CME

38 min listen

Nicole Lamanna, MD / Jennifer Woyach, MD - Seizing the Day With BTK Inhibitors in CLL: Evidence-Informed Therapy Selection, Safety, and Sequential Care: Go online to PeerView.com/QZB860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. by PeerView Internal Medicine CME/CNE/CPE Audio Podcast

89 min listen

Matthew S. Davids, MD, MMSc - Defying the Odds With Innovation in CLL: Perspectives on Personalized Care, Multiagent Platforms, and Sequential Strategies: Go online to PeerView.com/KYR860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. by PeerView Internal Medicine CME/CNE/CPE Audio Podcast

75 min listen

Clinical Context of the Consensus: A Review of the Latest Recommendations for Waldenström Macroglobulinemia: Did you know that the latest guidelines for Waldenström macroglobulinemia now encompass second-generation Bruton tyrosine kinase inhibitors? Credit available for this activity expires: 10/16/24 Earn Credit / Learning Objectives & Disclosures: by Keeping Current

34 min listen

Prof. Dr. med. Stephan Stilgenbauer - New Rules for BTK Inhibitors in CLL: Benchmarks for Evidence-Based Treatment Selection, Sequencing, and Safety Management: Go online to PeerView.com/DPX860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. by PeerView Internal Medicine CME/CNE/CPE Audio Podcast

88 min listen

Renal Denervation for High Blood Pressure: Long-Term Control or Short-Term Bandage?: Does renal denervation (RDN) provide durable blood pressure (BP) control? Expert hypertension (HTN) faculty discuss. Credit available for this activity expires: 5/8/25 Earn Credit / Learning Objectives & Disclosures: by Keeping Current CME

30 min listen

Jiwon Oh, MD, PhD, FRCPC - Moving Toward the Future in MS Management: What's the Latest on BTK Inhibition?: Go online to PeerView.com/WGE860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. by PeerView Internal Medicine CME/CNE/CPE Audio Podcast

33 min listen

A Deep Dive Into Long-Term Efficacy and Safety of LDL-Cholesterol Lowering: Modern Strategies for ASCVD: Are you up to date on low-density lipoprotein cholesterol (LDL-C)–lowering therapy in high-risk patients? Credit available for this activity expires: 06/06/25 Earn Credit / Learning Objectives & Disclosures: by Keeping Current

32 min listen

Dr. Toby A. Eyre, MBChB, DipMedEd, MRCP, FRCPath, MD / Anthony R. Mato, MD, MSCE - Upgrading the Sequential Therapy Tool Kit for B-Cell Malignancies: New Evidence on the Individualized Use of BTK Inhibitors in Relapsed/Refractory CLL/SLL and MCL: Go online to PeerView.com/DQM860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. by PeerView Internal Medicine CME/CNE/CPE Audio Podcast

69 min listen

$Dr. Toby A. Eyre, MBChB, DipMedEd, MRCP, FRCPath, MD / Anthony R. Mato, MD, MSCE - Upgrading the Sequential Therapy Tool Kit for B-Cell Malignancies: New Evidence on the Individualized Use of BTK Inhibitors in Relapsed/Refractory CLL/SLL and MCL: Go online to PeerView.com/DQM860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.$

Unlocking the Power of Tumor-Agnostic Therapy: A Path to Personalized Cancer Care: Are you aware of the currently approved tumor-agnostic drugs? Listen to the experts as they discuss them. Credit available for this activity expires: 06/21/25 Earn Credit / Learning Objectives & Disclosures: by Keeping Current

36 min listen

Benjamin M. Greenberg, MD, MHS & Professor Anthony Traboulsee, MD - Bruton Tyrosine Kinase Inhibitors for MS: Progress in the Development of an Emerging Therapeutic Approach: Go online to PeerView.com/NXB860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. by PeerView Internal Medicine CME/CNE/CPE Audio Podcast

49 min listen

Anthony R. Mato - The Rising Tide of Novel BTK Inhibitors: Case-Based Guidance on Overcoming Intolerance, Resistance, and Other Clinical Challenges in B-Cell Cancers: Go online to PeerView.com/CZP860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. by PeerView Internal Medicine CME/CNE/CPE Audio Podcast

60 min listen

Meeting of the Minds: Addressing the Gray Zone of Immunotherapy for Advanced Non-Small Cell Lung Cancer: View the experts discuss the ins and outs of immunotherapy for advanced non-small cell lung cancer (NSCLC) in the real world. Credit available for this activity expires: 11/30/2024 Earn Credit / Learning Objectives & Disclosures: by Keeping Current CME

40 min listen

Nicole Lamanna, MD - Building a Safety-Centric Culture in B-Cell Cancers: Interprofessional Insights on Optimizing BTKi Efficacy Through Safety Management: Go online to PeerView.com/TBV860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. by PeerView Internal Medicine CME/CNE/CPE Audio Podcast

53 min listen

Anthony R. Mato, MD, MSCE - Interprofessional Perspectives on Safety Management With Targeted Therapy for B-Cell Malignancies: Go online to PeerView.com/ECV860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. by PeerView Internal Medicine CME/CNE/CPE Audio Podcast

64 min listen